These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32959673)

  • 1. The Prevalence of Genital Human Papillomavirus Subtypes in a Cohort of Hispanic Women Presenting for Cervical Cancer Screening Along the US-Mexico Border.
    Shokar NK; Doan A; Calderon-Mora J; Lakshmanaswamy R; Ramadevi S; Shokar GS; Molokwu J; Alomari A; Dwivedi A
    Cancer Control; 2020; 27(1):1073274820951780. PubMed ID: 32959673
    [No Abstract]   [Full Text] [Related]  

  • 2. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
    Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
    BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
    Ali MAM; Bedair RN; Abd El Atti RM
    Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and genotype distribution of HPV among women attending a cervical cancer screening mobile unit in Lampang, Thailand.
    Paengchit K; Kietpeerakool C; Lalitwongsa S
    Asian Pac J Cancer Prev; 2014; 15(15):6151-4. PubMed ID: 25124589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
    Giuliano AR; Papenfuss M; Abrahamsen M; Denman C; de Zapien JG; Henze JL; Ortega L; Brown de Galaz EM; Stephan J; Feng J; Baldwin S; Garcia F; Hatch K
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1129-36. PubMed ID: 11700260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
    Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
    J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and correlates of cervical HPV infection in a clinic-based sample of HIV-positive Hispanic women.
    Ortiz AP; Tamayo V; Scorsone A; Soto-Salgado M; Febo I; Piovanetti P; Venegas-Ríos HL; Yamamura Y; Zorrilla C
    Papillomavirus Res; 2017 Dec; 4():39-44. PubMed ID: 29179868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Human Papillomavirus Genotypes in Women from Cozumel, Mexico.
    Navarro-Vidal E; Hernandez-Rosas F; Rey M; Flores-Peredo L
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2417-2422. PubMed ID: 30255694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypes distribution of human papillomavirus in cervical samples of Ecuadorian women.
    García Muentes GD; García Rodríguez LK; Burgos Galarraga RI; Almeida Carpio F; Ruiz Cabezas JC
    Rev Bras Epidemiol; 2016 Mar; 19(1):160-6. PubMed ID: 27167657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus prevalence at the USA-Mexico border among women 40 years of age and older.
    Giuliano AR; Papenfuss MR; Denman CA; de Zapien JG; Abrahamsen M; Hunter JB
    Int J STD AIDS; 2005 Mar; 16(3):247-51. PubMed ID: 15829027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia.
    Panigoro R; Susanto H; Novel SS; Hartini S; Sahiratmadja E
    Asian Pac J Cancer Prev; 2013; 14(10):5843-7. PubMed ID: 24289587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of human papillomavirus genotyping.
    Choi YJ; Park JS
    J Gynecol Oncol; 2016 Mar; 27(2):e21. PubMed ID: 26768784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta.
    Castle PE; Gage JC; Partridge EE; Rausa A; Gravitt PE; Scarinci IC
    BMC Infect Dis; 2013 Jan; 13():5. PubMed ID: 23289357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevaccination distribution of human papillomavirus types in Italian women with high-risk lesions and cervical neoplasia.
    De Francesco MA; Gargiulo F; Schreiber C; Ciravolo G; Salinaro F; Manca N
    Intervirology; 2010; 53(6):417-25. PubMed ID: 20606464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific and genotype-specific carcinogenic human papillomavirus prevalence in a country with a high cervical cancer burden: results of a cross-sectional study in Estonia.
    Pärna K; Nygård M; Tisler A; Toompere K; Naaber P; Ratnik K; Ķīvīte Urtāne A; Zodzika J; Stankūnas M; Baltzer N; Uusküla A
    BMJ Open; 2023 Jun; 13(6):e069558. PubMed ID: 37263686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV Genotype Prevalence and Success of Vaccination to Prevent Cervical Cancer.
    Leite KRM; Pimenta R; Canavez J; Canavez F; de Souza FR; Vara L; Estivallet C; Camara-Lopes LH
    Acta Cytol; 2020; 64(5):420-424. PubMed ID: 32235115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.